Laura Bojke
Senior Research Fellow

Profile

Biography

Laura graduated in business economics in 1998, went on to complete an MSc in health economics at York and a PhD titled 'Characterizing structural uncertainty within decision analytic models in 2008, also at York. She joined the economic evaluation team in 1999.

Her research interests include:

  • The assessment and implications of structural uncertainty within decision analytic models
  • The use of elicited data within decision analytic models
  • The application of methods of evidence synthesis within a decision analytic framework

Research

Overview

  • The assessment and implications of structural uncertainty within decision analytic models 
  • The use of elicited data within decision analytic models
  • Extrapolating costs and benefits beyond evidence 
  • Value based pricing, effective price changes and managed entry

Research group(s)

Teaching

Other teaching

Publications

Full publications list

2013

  • Longworth L, Youn J, Bojke L, Palmer S, Griffin S, Spackman E, Claxton, K. When does NICE recommend the use of Health technologies within a programme of evidence development? : A systematic review of NICE guidance. Pharmacoeconomics  2013;31(2):137-49.
  • Soares MO, Dumville J, Ashby RL, Iglesias Urrutia CP, Bojke L, Adderley UJ, McGinnis E, Stubbs N, Torgerson D, Claxton K, Cullum N. Methods to assess cost effectiveness and value of further research when data are sparse: Negative-pressure wound therapy for severe pressure ulcers. Medical Decision Making 2013;33(3):415-36.

2012

  • Bojke L, Spackman E, Hinde S, Helliwell P. Capturing all of the costs in NICE appraisals: the impact of inflammatory rheumatic diseases on productivity. Rheumatology 2012;51(2):210-215.
  • Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman DE, Youn J. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technology Assessment 2012;16. Download from hta
  • Soares MO, Dumville J, Ashby R, Iglesias C, Bojke L, Adderley U, McGinnis E, Stubbs N, Torgerson D, Claxton K, Cullum N. Methods to assess cost effectiveness and value of further research when data are sparse: negative pressure wound therapy for severe pressure ulcers. Medical Decision Making 2012;doi:10.1177/0272989X12451058. Download from sagepub
  • Yang H, Craig D, Epstein D, Bojke L, Light K, Bruce I, Sculpher M, Woolacott N. Golimumab for the treatment of psoriatic arthritis: A NICE Single Technology Appraisal. Pharmacoeconomics 2012;30:257-70.

2011

  • Bojke L, Epstein D, Craig D, Rodgers M, Woolacott N, Yang H, Sculpher M. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. Rheumatology 2011;50:iv39-iv47.
  • Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman E, Youn J. Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies. Centre for Health Economics, University of York; CHE Research Paper 69 (PDF , 1,860kb)‌‎ 2011.
  • Jackson CH, Bojke L, Thompson SG, Claxton K, Sharples LD. A framework for addressing structural uncertainty in decision models. Medical Decision Making 2011;31(4):662-674. Download from sagepub
  • Longworth L, Sculpher M, Bojke L, Tosh J. Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. International Journal of Technology Assessment in Health Care 2011;27(2):180-7. Download from pubmed
  • Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess 2011;15(10):1-329. Download from HTA
  • Soares MO, Bojke L, Dumville J, Iglesias C, Callum N, Claxton K. Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration. Statistics in Medicine 2011;30(19):2363-2380. Download from Wiley

2010

  • Bojke L, Claxton K, Bravo Vergel Y, Sculpher M, Palmer S, Abrams K. Eliciting distributions to populate decision analytic models. Value in Health 2010;13:557-64. Download from Wiley interscience

2009

  • Epstein D, Bojke L, Sculpher M & the REFLUX trial group. The cost-effectiveness of laparoscopic fundoplication versus medical management for gastro oesophageal reflux disease. British Medical Journal 2009;338:b2576.
  • Bojke L, Claxton K, Sculpher M, Palmer S. Characterizing structural uncertainty in decision-analytic models: a review and application of methods. Value in Health. 2009;12:739-49.
  • McKenna C, Bojke L, Manca A, et al. Shoulder acute pain in primary healthcare: is retraining GP's effective (SAPPHIRE) randomised trial - cost effectiveness analysis. Rheumatology, advance access published on March 2009; doi:10.1093/rheumatology/kep008
  • Longworth L, Bojke L, Tosh J, Sculpher M. MRC-NICE scoping project: identifying the national institute for health and clinical excellence’s methodological research priorities and an initial set of priorities. Centre for Health Economics, University of York; CHE Research Paper 51 (PDF , 546kb)‌‎ 2009.

2008

  • Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technology Assessment. 2008;12(31):1-204.
  • Bojke L, Claxton K, Sculpher M, Palmer S, Philips Z. The cost-effectiveness and value for information associated with repeat screening for age related macular degeneration. Medical Decision Making. 2008;28:33-43. Download from Sage journals online 

2007

  • Bojke L, Hornby E, Sculpher M; on behalf of the REFLUX Trial Team. A comparison of the cost effectiveness of pharmacotherapy or surgery (laporoscopic fundoplication) in the treatment of GORD. Pharmacoeconomics. 2007;25(10):829-41. Download from Ingenta connect 
  • Colbourn T, Asseburg C, Bojke L, Philips Z, Welton N, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. British Medical Journal. 2007;Sept 29;335(7621):655.
  • Colbourn T, Asseburg C, Bojke L, Phillips Z, Claxton K, Ades A, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses  Health Technology Assessment. 2007;11(29):1-208. Download from NIHR Health Technology Assessment programme

2006

  • Bojke L, Claxton K, Palmer S, Sculpher M. Defining and characterising structural uncertainty in decision analytic models. Centre for Health Economics, University of York; CHE Research Paper 9 (PDF , 229kb)‌‎ , 2006.
  • Philips Z, Bojke L, Sculpher M, Claxton K, Golder S. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality of assessment. Pharmacoeconomics. 2006;24:355-71.
  • Philips Z, Palmer S, Ginnelly L, Claxton K, Sculpher M. Priority setting for research in healthcare: an application of value of information analysis to glycoprotein IIb/IIIa antagonists in non-ST elevation acute coronary syndrome. International Journal of Technology Assessment in Healthcare, 2006;22(3):379-387. Priority setting for research in healthcare (PDF , 68kb)‌‎.
  • Whiting P, Westwood M, Bojke L, Palmer S, Richardson G, Cooper J, Watt I, Glanville J, Sculpher M, Kleijnen J. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technology Assessment 2006;10(36). 

2005

  • Claxton K, Eggington S, Ginnelly L, Griffin S, McCabe C, Philips Z, et al. A pilot study of value of information analysis to support research recommendations for the National Institute for Health and Clinical Excellence. Centre for Health Economics, University of York; CHE Research Paper 4 (PDF , 1,149kb)‌‎ 2005.
  • Epps H, Ginnelly L, Utley M, Southwood T, Gallivan S, Sculpher M, et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technology Assessment 2005;9(39):1-76.
  • Ginnelly L, Sculpher M, Bojke C, DiGuseppi C, Roberts I, Wade A. Determining the cost effectiveness of a smoke alarm give-away program using data from a randomised controlled trial. European Journal of Public Health 2005;15:448-453.
  • Ginnelly L, Claxton K, Sculpher MJ, Golder S. Using value of information analysis to inform publicly funded research priorities. Applied Health Economics and Health Policy 2005;4:37-46.
  • Philips Z, Claxton KP, Palmer S, Bojke L, Sculpher MJ (2006). Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/IIIa antagonists in non-ST elevation acute coronary syndrome. International Journal of Technology Assessment in Health Care 2006;22:379-387.
  • Palmer S, Sculpher M, Philips Z, Robinson M, Ginnelly L, Bakhai A, et al. Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIa antagonists in the UK National Health Service? International Journal of Cardiology 2005;100:229-240.
  • Robinson M, Palmer S, Sculpher MJ, Philips Z, Ginnelly L, Bowens A, et al. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision analytic modelling. Health Technology Assessment 2005;9:1-172.

2004

  • Smith PC, Ginnelly L, Sculpher M. (eds) Health policy and economics. Opportunities and challenges. Maidenhead: Open University Press; 2004.
Staff Photo for Laura Bojke

Contact details

Laura Bojke
Senior Research Fellow
Centre for Health Economics